Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological ActivitiesXiaoying Jiang, Yuanyuan Xie, Tao Zhou et al.|Journal of Medicinal Chemistry|2020Cited by 51
Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activityXiaoying Jiang, Yuanyuan Xie, Jianan Guo et al.|Bioorganic & Medicinal Chemistry|2020Cited by 39
Dual-target anti-Alzheimer’s disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activityZhisheng Mi, Yuanyuan Xie, Sihang Yu et al.|Journal of Enzyme Inhibition and Medicinal Chemistry|2019Cited by 35
Design, synthesis and biological evaluation of potential anti-AD hybrids with monoamine oxidase B inhibitory and iron-chelating effectsJianan Guo, Yuanyuan Xie, Zhisheng Mi et al.|Bioorganic Chemistry|2020Cited by 18
N-Propargylamine-hydroxypyridinone hybrids as multitarget agents for the treatment of Alzheimer’s diseaseJianan Guo, Yuanyuan Xie, Yujia Zhang et al.|Bioorganic Chemistry|2021Cited by 18